| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.068 | 0.02 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.02 |
| mRNA | BHG712 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.12 | 0.02 |